ShangPharma Announces Strategic Corporate Restructuring of … – PR Newswire (press release)
Currently, Shanghai ChemPartner’s intention is to enter the capital market in China, mainly through a merger approach. By listing on either the Shanghai or Shenzhen stock exchange, ChemPartner seeks to leverage the capital market in China. Similar strategies have been adopted by several industry leaders. “ShangPharma is committed to the best interests of our employees,…

